PubRank

Hans Petersen

Author PubWeight™ 32.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007 4.96
2 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med 2015 4.16
3 New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med 2011 2.07
4 Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med 2014 1.77
5 Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med 2010 1.10
6 An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm 2006 1.09
7 Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis 2011 1.02
8 Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD. J Med Econ 2009 0.90
9 Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care 2010 0.87
10 Methylated Genes in Sputum Among Older Smokers With Asthma. Chest 2012 0.87
11 Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. J Med Econ 2011 0.86
12 Prevalence of Bartonella infection in domestic cats in Denmark. Vet Res 2002 0.85
13 Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol 2008 0.84
14 Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf 2010 0.84
15 Economic burden of chronic bronchitis in the United States: a retrospective case-control study. Int J Chron Obstruct Pulmon Dis 2011 0.82
16 Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States. J Asthma 2010 0.82
17 Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res 2014 0.82
18 Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients. Ann Am Thorac Soc 2015 0.81
19 Latent variable mixture modeling: a flexible statistical approach for identifying and classifying heterogeneity. Nurs Res 2012 0.81
20 A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. Ann Am Thorac Soc 2015 0.81
21 Features indicative of cervical abnormality. A factor to be reckoned with in clinical headache work and research? Funct Neurol 2004 0.79
22 Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol 2013 0.79
23 Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population. Am J Geriatr Pharmacother 2012 0.78
24 Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction. Chest 2015 0.77
25 Relationship between short-acting β2-adrenergic agonist use and healthcare costs. Am J Manag Care 2011 0.76
26 Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma. J Asthma 2013 0.76
27 Reply from the authors. Am J Respir Crit Care Med 2014 0.75